Bullboard - Stock Discussion Forum Aldeyra Therapeutics Inc ALDX

Healthcare Biotechnology

Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in discovering therapies designed to treat immune-mediated diseases. The Company's product candidates include reactive aldehyde species (RASP) modulators ADX-629, ADX-246, ADX-248, and chemically related molecules for the treatment of systemic and retinal immune-mediated diseases. Its pre-commercial product candidates are... see more

Add To Watchlist

NDAQ:ALDX - Post Discussion

Aldeyra Therapeutics Inc > Aldeyra Therapeutics Announces FDA Acceptance for Review of

View:

Post by whytestocks on Nov 18, 2024 11:30am

Aldeyra Therapeutics Announces FDA Acceptance for Review of

News; $ALDX Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option AgreementPDUFA Date is April 2, 2025 Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for topical ocular reproxalap, a first-in-class investigational new d...ALDX - Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement